1Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J (1991) Follicular Hürthle cell tumors of the thyroid gland. Cancer 68: 1944-1953.

2McLeod MK, Thompson NW (1990) Hürthle cell neoplasms of the thyroid. Otolaryngol Clin North Am 23:441-452.

3Kanthan R, Radhi JM (1998) Immunohistochemical analysis of thyroid adenomas with Hürthle cells. Pathology 30:4-6.

4Erickson LA, Jin L, Goellner JR, Lohese C, Pankratz VS, et al. (2000) Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid. Mod Pathol 13:186-192.

5CarcangiuML, Steeper T, Zampi G, Rosai J (1985) Anaplastic thyroid carcinoma: a study of 70 cases. Am J Clin Pathol 83:135-158.

6Kapp D, LiVolsi V, Sanders M (1982) Anaplastic carcinoma following well differentiated thyroid cancer: etiologic considerations. Yale J Biol Med 55:521-528.

7Mai DD, Mai KT, Shamji FM (2001) Fine needle aspiration biopsy of anaplastic thyroid carcinoma developing from a Hürthle cell tumor: a case report. Acta Cytol 45:761-764.

8Stucchi CM, Vaccaro V, Magherini A, Di Gregorio C, Greco G, et al. (2007) Hürthle cell follicular carcinoma of the thyroid gland presenting with diffuse meningeal carcinomatosis and evolving to anaplastic carcinoma. J Clin Pathol 60:831-832.

9Hunt JL, Tometsko M,LiVolsi VA, Swalsky P, Finkelstein SD, et al. (2003) Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid. Am J Surg Pathol 27:1559-1564.

10Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, et al. (1990) Anaplastic carcinoma of the thyroid. A Clinicopathologic study of 121 cases. Cancer 66:321-330.

11Aratake Y, Nomura H, Kotani T, Marutsuka K, Kobayashi K, et al. (2006) Coexistant anaplastic and differentiated thyroid carcinoma: an immunohistochemical study. Am J Clin Pathol 125:399-406.

12Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, et al. (2007) Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment. Ann Surg Oncol14:719-729.

13Wiseman SM, Griffith OL, Deen S, Rajput A, Masoudi H, et al. (2007) Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma. Arch Surg 142:717-727.

14Baloch ZW, LiVolsi VA (2008) Fine-needle aspiration of the thyroid: today and tomorrow. Best Pract Res Clin Endocrinol Metab 22:929-939.

15Rosai J, Carcangiu ML, DeLellis RA, Simoes MS (2000) Recommendations for the reporting of thyroid carcinomas. Association of directors of anatomic and surgical pathology. Hum Pathol 31:1199-1201.

16Elliott DD, Pitman MB, Bloom L, Faquin WC (2005) Fine-needle aspiration biopsy of Hürthle cell lesions of the thyroid gland: a cytomorphologic study of 139 cases with statistical analysis. Cancer 108:102-109.

17Eilers SG, LaPolice P, Mukunyadzi P, Kapur U, Wendel Spiczka A, et al. (2014) Thyroid fine-needle aspiration cytology: performance data of neoplastic and malignant cases as identified from 1558 responses in the ASCP non-GYN assessment program thyroid fine-needle performance data. Cancer Cytopathol 112:745-750.

18Hoos A, Stojadinovic A, Singh B, Dudas ME, Leung DHY, et al. (2002) Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays. Am J Pathol 160:175-183.